Intervention

Whole brain radiotherapy

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

2 shown

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR MutationNCT01516983 · 2011-12-01

Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)NCT00266812 · 2005-03-08

Common conditions

Brain Metastases1 Carcinoma, Non-Small-Cell Lung1 Non-small Cell Lung Cancer1

Leading sponsors

Betta Pharmaceuticals Co., Ltd.1 Merck Sharp & Dohme LLC1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.